Navigation Links
Surveyed U.S. and European Neurologists Agree that a Therapy's Effect on Physical Disability is the Most Important Attribute Influencing Prescribing Decisions in Secondary-Progressive Multiple Sclerosis
Date:3/20/2013

BURLINGTON, Mass., March 20, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European neurologists agree that a therapy's effect on physical disability is the most influential attribute when making prescribing decisions for secondary-progressive multiple sclerosis (SP-MS)*. These same neurologists cite a therapy's effect on quality of life as the second-most important attribute, ahead of an effect on relapses, imaging metrics and other functional domains.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO)

Current management of SP-MS relies on the use of mainline disease-modifying therapies (which include interferon-betas and Teva's Copaxone), most of which are approved broadly for the treatment of relapsing forms of MS. This category encompasses relapsing-remitting MS (RR-MS) and SP-MS patients who continue to experience relapses. Interviewed thought leaders suggest that, based on data in RR-MS, Genzyme/Sanofi/Bayer HealthCare's Lemtrada may offer advantages over sales-leading Copaxone on measures of physical disability—potentially translating into clinical benefits for SP-MS patients. 

"The neurologists we surveyed indicate that an improved effect on physical disability is one of the greatest unmet needs in SP-MS," said Decision Resources Analyst Georgiana L. Kuhlmann , S.M. "Drawing on clinical data from RR-MS trials, interviewed thought leaders indicate that Lemtrada has demonstrated the potential to partially fulfill this unmet need."

According to the DecisionBase 2013 report entitled On What Attributes Will Neurologists and Payers Differentiate Novel Therapies for Secondary-Pro
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. According to Surveyed Oncologists in the EU5, Zytiga Has Heavily Penetrated Second-Line Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC) and is Displacing Jevtana to Later-Line mCRPC
2. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
3. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
4. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
5. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
6. Mylan Launches Generic Lipitor® in Five European Countries
7. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
8. Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
9. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
10. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
11. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... Investor-Edge has initiated coverage on the ... Corporation (NASDAQ: GERN ), Tekmira Pharmaceuticals Corporation (NASDAQ: ... GALE ), and XOMA Corporation (NASDAQ: XOMA ). ... http://investor-edge.com/register . The US markets on Monday, ... Dow Jones Industrial Average finished at 17,647.75, up 0.07% and ...
(Date:11/18/2014)... Nov. 18, 2014 BioLink 2015, the ... Transfer Summit, co-organized by CCCMHPIE ( China Chamber ... Medicines & Health Products), UBM Live and Beijing ... 23rd, 2015 at Beijing Yizhuang Biomedical Park. ... This event will gather 200+ decision ...
(Date:11/18/2014)...   Rio Grande Valley Health Information Exchange (RGV ... Health Science Center at Houston (UTHealth)  School of Public ... selected Wellcentive,s suite of population health management solutions and ... to partner with hospitals and clinics in the region ... uninsured patient populations, initially focusing on the care of ...
Breaking Medicine Technology:Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 3Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 5BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 2BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 3Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 2Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 3Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 4
... Dynatronics Corporation (Nasdaq: DYNT ) announced ... RB Milestone Portfolio, a group of companies selected by ... the market via a combination of traditional and innovative ... Network™, and non-deal roadshows, with a focus on the ...
... 16, 2011 McGraw-Hill Professional, a leading ... scientific and medical communities, and Simbionix™, the ... simulation technology, have partnered to bring surgical ... training resource AccessSurgery™ ( www.accesssurgery.com ) to ...
Cached Medicine Technology:Dynatronics Selected for Inclusion in RB Milestone Portfolio 2McGraw-Hill Professional and Simbionix™ Partner to Provide Enhanced Surgical Simulation and Education 2
(Date:11/21/2014)... 2014 Saint Luke’s Mid America ... Guidelines®–Heart Failure Gold-Plus Quality Achievement Award for implementing ... Heart Association/American College of Cardiology Foundation in their ... Get With The Guidelines–Heart Failure is a quality ... most up-to-date, research-based guidelines with the goal of ...
(Date:11/21/2014)... Reston, VA (PRWEB) November 21, 2014 ... Care App (ECA) is an all-in-one senior care coordination ... data on loved ones simple and intuitive for family ... adult day care centers). Now, the family caregiver or ... track their daily activities, health data, medical records, goals, ...
(Date:11/21/2014)... Recently, DressVe.com , a renowned women’s dress wholesaler and ... of fashion accessories. Furthermore, the company has launched its Special ... on all its fashion items. Also, orders above $59 are ... the company, their wedding dresses and prom dresses are very ... discounted rates. , The CEO says “We are glad ...
(Date:11/21/2014)... York, NY (PRWEB) November 21, 2014 ... burden for its intended parents — and at the same ... a renewed sense of optimism for future parents across the ... success. , Prospective parents today are zoning in on ... However, beyond the encumbering costs, are individuals over-stressing clinical ...
(Date:11/21/2014)... DC; London, UK (PRWEB) November 21, 2014 ... the world’s only ISO verified healthcare professional panel, today announced ... growth: the appointment of Roni DasGupta as President of Market ... Director of Market Research, Europe. , Ms. DasGupta ... Senior Vice President and most recently Head of Sales. ...
Breaking Medicine News(10 mins):Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Comprehensive Senior Care Application Launched on Apple App Store 2Health News:DressVe.com Announces Its 2014 Special Friday Sales 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 3Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2
... a new vaccine against childhood pneumonia, meningitis and ear ... Meanwhile, doctors are directing the supplies they do have ... such as those with sickle cell anemia, the AIDS ... ,PREVNAR fights the bacterium streptococcus pneumoniae, the leading ...
... in France, despite a diet rich in butter and other ... red wine, another staple of the French diet. //Scientists say ... explanation is pigments known as polyphenols. ,Polyphenols ... of the arteries. Polyphenols in red wine decreases the amount ...
... to a new study, there is no significant difference ... serotonin reuptake inhibitors (SSRIs) are now very widely used ... a brain chemical called serotonin that plays an important ... how individual SSRIs compare with one another. However, a ...
... A team of UK scientists has found six genes which ... that eventually, doctors will be able to gauge an individual ... genetic makeup.Only a small proportion of breast cancer cases are ... ,Two genes have already been firmly linked with some ...
... a new study alcoholics are prone to a kind of ... the study of alcohol on the health of aged people ... of persistent problem drinking were 20 per cent more likely ... Heavy drinkers ran a 10 per cent greater risk. These ...
... it thins the blood and prevents the clots that ... class of pain relievers known as nonsteroidal anti-inflammatory drugs.// ... and pains. The popular pain reliever ibuprofen blocks the ... sounds a warning for people who take both medicines. ...
Cached Medicine News:
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: